Re: Drug Adherence and Clinical Outcomes for Patients Under Pharmacological Therapy for Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Population-based Cohort Study.

作者信息

Gravas Stavros

机构信息

Department of Urology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Feidiou 6-8, Larissa 41221, Greece..

出版信息

Eur Urol. 2015 Aug;68(2):338-9. doi: 10.1016/j.eururo.2015.03.015.

DOI:10.1016/j.eururo.2015.03.015

PMID:26149729

Abstract

摘要

相似文献

Re: Drug Adherence and Clinical Outcomes for Patients Under Pharmacological Therapy for Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Population-based Cohort Study.

Eur Urol. 2015 Aug;68(2):338-9. doi: 10.1016/j.eururo.2015.03.015.

Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study.

Eur Urol. 2015 Sep;68(3):418-25. doi: 10.1016/j.eururo.2014.11.006. Epub 2014 Nov 20.

Adherence to therapy for lower urinary tract symptoms: don't mistake association with causation!

Eur Urol. 2015 Sep;68(3):426-7. doi: 10.1016/j.eururo.2015.02.006. Epub 2015 Feb 19.

Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms.

N Engl J Med. 2012 Jul 19;367(3):248-57. doi: 10.1056/NEJMcp1106637.

Drug adherence and drug-related problems in pharmacotherapy for lower urinary tract symptoms related to benign prostatic hyperplasia.

J Physiol Pharmacol. 2018 Aug;69(4). doi: 10.26402/jpp.2018.4.14. Epub 2018 Dec 9.

Treatment of benign prostatic hyperplasia.

Rev Assoc Med Bras (1992). 2017 Feb;63(2):95-99. doi: 10.1590/1806-9282.63.02.95.

Re: Twelve-Month Medication Persistence in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia.

J Urol. 2015 Oct;194(4):1056. doi: 10.1016/j.juro.2015.07.026. Epub 2015 Jul 15.

Benign Prostatic Hyperplasia.

Prim Care. 2019 Jun;46(2):223-232. doi: 10.1016/j.pop.2019.02.003. Epub 2019 Apr 1.

Medical treatment for benign prostatic hyperplasia: Where do we stand?

Urologia. 2019 Aug;86(3):115-121. doi: 10.1177/0391560319859785. Epub 2019 Jul 8.

Finasteride or dutasteride for the pharmacological treatment for male lower urinary tract symptoms due to benign prostatic hyperplasia?

Actas Urol Esp. 2016 May;40(4):268-9. doi: 10.1016/j.acuro.2015.12.006. Epub 2016 Jan 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验